tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

CATX Stock Latest News

Perspective Therapeutics Updates Corporate Presentation on Pipeline
Company AnnouncementsPerspective Therapeutics Updates Corporate Presentation on Pipeline
3d ago
8K
CATX
Perspective Therapeutics Updates Executive Employment Agreements
PremiumCompany Announcements
Perspective Therapeutics Updates Executive Employment Agreements
5d ago
8K
CATX
Perspective Therapeutics Advances in Neuroendocrine Tumor Therapy with Promising Clinical Study
PremiumCompany Announcements
Perspective Therapeutics Advances in Neuroendocrine Tumor Therapy with Promising Clinical Study
12d ago
CATX
Perspective Therapeutics Advances Cancer Treatment with Innovative Clinical Study
PremiumCompany Announcements
Perspective Therapeutics Advances Cancer Treatment with Innovative Clinical Study
12d ago
CATX
Perspective Therapeutics’ Innovative Melanoma Trial: A Potential Game-Changer
PremiumCompany Announcements
Perspective Therapeutics’ Innovative Melanoma Trial: A Potential Game-Changer
12d ago
CATX
Hold Rating for Perspective Therapeutics Amid Efficacy Concerns and Competitive Challenges
PremiumRatingsHold Rating for Perspective Therapeutics Amid Efficacy Concerns and Competitive Challenges
19d ago
CATX
Positive Outlook on Perspective Therapeutics Amidst Challenges: Buy Rating Reiterated with $14 Target
Premium
Ratings
Positive Outlook on Perspective Therapeutics Amidst Challenges: Buy Rating Reiterated with $14 Target
19d ago
CATX
Perspective Therapeutics falls after update on Phase 1/2a trial
Premium
The Fly
Perspective Therapeutics falls after update on Phase 1/2a trial
19d ago
CATX
Positive Long-Term Outlook for Perspective Therapeutics Despite Mixed ORR Results
PremiumRatings
Positive Long-Term Outlook for Perspective Therapeutics Despite Mixed ORR Results
20d ago
CATX
Perspective Therapeutics Shows Promising Trial Results at ESMO
PremiumCompany Announcements
Perspective Therapeutics Shows Promising Trial Results at ESMO
20d ago
8K
CATX
Perspective Therapeutics initiated with a Buy at BTIG
PremiumThe Fly
Perspective Therapeutics initiated with a Buy at BTIG
30d ago
CATX
Positive Buy Rating for Perspective Therapeutics Driven by Promising Clinical Progress and Market Potential of FAP-Targeted Therapy
PremiumRatings
Positive Buy Rating for Perspective Therapeutics Driven by Promising Clinical Progress and Market Potential of FAP-Targeted Therapy
1M ago
CATX
Perspective Therapeutics announces first patient treated with PSV359
PremiumThe FlyPerspective Therapeutics announces first patient treated with PSV359
1M ago
CATX
Perspective Therapeutics Updates Radiopharmaceutical Advancements
Premium
Company Announcements
Perspective Therapeutics Updates Radiopharmaceutical Advancements
1M ago
8K
CATX
Optimistic Buy Rating for Perspective Therapeutics Driven by Promising Trial Results and Upcoming Catalysts
Premium
Ratings
Optimistic Buy Rating for Perspective Therapeutics Driven by Promising Trial Results and Upcoming Catalysts
2M ago
CATX
Perspective Therapeutics: Promising Developments and Strong Buy Rating Amidst Encouraging Clinical Trial Results
PremiumRatings
Perspective Therapeutics: Promising Developments and Strong Buy Rating Amidst Encouraging Clinical Trial Results
2M ago
CATX
Oppenheimer more confident Perspective’s VMT update will build on prior results
PremiumThe Fly
Oppenheimer more confident Perspective’s VMT update will build on prior results
2M ago
CATX
Perspective announces first patient dosed in cohort of Phase 1/2a trial
PremiumThe Fly
Perspective announces first patient dosed in cohort of Phase 1/2a trial
2M ago
CATX
3 Best Stocks to Buy Now, 9/11/2025, According to Top Analysts
PremiumMarket News
3 Best Stocks to Buy Now, 9/11/2025, According to Top Analysts
2M ago
CATX
ONON
Perspective Therapeutics Appoints Joel Sendek as CFO
PremiumCompany AnnouncementsPerspective Therapeutics Appoints Joel Sendek as CFO
2M ago
8K
CATX
Perspective Therapeutics appoints Joel Sendek as CFO
Premium
The Fly
Perspective Therapeutics appoints Joel Sendek as CFO
2M ago
CATX
Perspective Therapeutics management to meet with Oppenheimer
Premium
The Fly
Perspective Therapeutics management to meet with Oppenheimer
2M ago
CATX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >